59602 Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 

and the IHS. The purpose of the 

agreement is to support NIHB assistance 

to the Agency in developing a strategic 

plan to improve CMS’ services to 

eligible AI/AN beneficiaries. This is 

consistent with goals in the scope of 

work in which NIHB seeks to establish 

relationships with Federal agencies to 

service as a health advocate for AI/AN 

people and expand services to them 

from other HHS agencies. 

4. Assistance in the implementation 

of the IHS Director’s Health Promotion/

Disease Prevention (HP/DP) Initiative. 

The Director, IHS, has announced this 

initiative in conjunction with President 

Bush’s ‘‘Healthier U.S. Initiative’’ and 

HHS Secretary Thompson’s ‘‘Steps to a 

Healthier U.S.’’ to reduce health 

disparities among AI/AN people. This 

initiative is a strategic approach to 

strengthening prevention efforts to 

improve the health and wellness of AI/

AN families through expanded 

collaboration with Federal and nonFederal partners. The IHS will support 

this prevention effort, in part, through a 

partnership with NIHB in promoting 

physical activity in AI/AN communities 

under a program called ‘‘Just Move it.’’

The NIHB will assist the IHS in 

managing this particular HP/DP 

Initiative by hosting a Web site for 

Tribal communities to become ‘‘Just 

Move It’’ partners, marketing this effort 

to Tribes, etc. These activities are 

consistent with the NIHB goals of 

systematically disseminating pertinent 

and timely health care information to 

AI/AN communities and establishing 

relationships with other organizations to 

serve as advocates for improved Indian 

health. 

5. Assistance to the IHS in the 

evaluation of the current relationships 

between schools of public health and 

AI/AN communities. 

In order to determine the current 

relationships between schools of public 

health and AI/AN communities, the 

NIHB will assist the IHS in developing 

a baseline report of research activities 

and existing partnerships. The NIHB 

will serve in an advisory capacity to the 

IHS and the Association of Schools of 

Public Health on this initiative. The 

organization has the expertise and 

experience to provide technical 

assistance on issues related to working 

in Indian Country such as 

infrastructure, Tribal Government 

protocols, cultural and legal aspects of 

sovereignty, and the appropriateness of 

products and deliverables. The objective 

of this effort will result in 

recommendations on improving the 

public health infrastructure in AI/AN 

communities. The purpose of this report 

is consistent with the NIHB goals of 

developing relationships with other 

organizations and professional groups in 

order to serve as an advocate for 

improved AI/AN health care. 

Justification for Single Source 

This project has been awarded on a 

non-competitive, single-source basis. 

The NIHB is the only national AI/AN 

organization with health expertise that 

represents the interest of all federally 

recognized Tribes. 

Use of Cooperative Agreement 

The program supplement to the 

original cooperative agreement has been 

awarded because of anticipated 

substantial programmatic involvement 

by IHS staff in the project. The 

substantial programmatic involvement 

includes the following: 

(1) The IHS staff will have approval 

over the hiring of key personnel as 

defined by regulation or provision in the 

cooperative agreement. 

(2) The IHS will provide technical 

assistance to the NIHB as requested and 

attend and participate in all NIHB board 

meetings.

FOR FURTHER INFORMATION CONTACT: Mr. 

Douglas Black, Director, Office of Tribal 

Programs, Office of the Director, Indian 

Health Service, 801 Thompson Avenue, 

Reyes Building, Suite 220 Rockville, 

Maryland 20852, (301) 443–1104. For 

grants information, contact Ms. Sylvia 

Ryan, Grants Management Specialist, 

Division of Grants Policy, 12300 

Twinbrook Parkway, Suite 100, 

Rockville, Maryland 20852, (301) 443–

5204.

Dated: September 28, 2004. 

Charles W. Grim, 

Assistant Surgeon General, Director, Indian 

Health Service.

[FR Doc. 04–22333 Filed 10–4–04; 8:45 am] 

BILLING CODE 4160–16–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 PBC 

01Q: Pathobiochemistry: Quorum. 

Date: October 15, 2004. 

Time: 8:30 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points By Sheraton, 8400 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Zakir Bengali, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5150, 

MSC 7842, Bethesda, MD 20892, (301) 435–

1742, bengaliz@csr.nih.gov.

Name of Committee: Oncological Sciences 

Integrated Review Group, Drug Discovery 

and Molecular Pharmacology Study Section. 

Date: October 20–22, 2004. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Arlington, 1325 Wilson 

Boulevard, Arlington, VA 22209. 

Contact Person: Morris I. Kelsey, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6158, 

MSC 7804, Bethesda, MD 20892, 301–435–

1718, kelseym@csr.nih.gov.

Name of Committee: Endocrinology, 

Metabolism, Nutrition and Reproductive 

Sciences Integrated Review Group, Cellular 

Aspects of Diabetes and Obesity Study 

Section. 

Date: October 21–22, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Ann A. Jerkins, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6154, 

MSC 7892, Bethesda, MD 20892, 301–435–

4514, jerkinsa@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Basic 

Mechanisms of Cancer Therapeutics. 

Date: October 21–22, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Watergate, 2650 Virginia 

Avenue, NW., Washington, DC 20037.

Contact Person: Suzanne L. ForrySchaudies, PhD, Scientific Review 

Administrator, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Dr., Room 6192, MSC 7804, Bethesda, MD 

20892, (301) 451–0131, forryscs@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 MGA 

(01) Q: Molecular Genetics A: Quorum. 

Date: October 21–22, 2004. 

Time: 8 a.m. to 5 p.m. 

Federal Register / Vol. 69, No. 192 / Tuesday, October 5, 2004 / Notices 59603

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Michael M. Sveda, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5152, 

MSC 7842, Bethesda, MD 20892, 301–435–

3565, svedam@csr.nih.gov.

Name of Committee: Musculoskeletal, Oral 

and Skin Sciences Integrated Review Group, 

Oral, Dental and Craniofacial Sciences Study 

Section. 

Date: October 26–27, 2004. 

Time: 8:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The River Inn, 924 25th Street, NW., 

Washington, DC 20037. 

Contact Person: J. Terrell, Hoffeld, DDS, 

PhD, Dental Officer, USPHS, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4116, 

MSC 7816, Bethesda, MD 20892, 301–435–

1781, hoffeldt@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, ZRG1 

EMNR–A 02: Member Conflict. 

Date: October 28, 2004. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Syed M. Amir, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6172, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1043, amirs@csr.nih.gov.

Name of Committee: Health of the 

Population Integrated Review Group, 

Biostatistical Methods and Research Design 

Study Section. 

Date: October 29, 2004. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037. 

Contact Person: Ann Hardy, DRPH, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3158, 

MSC 7770, Bethesda, MD 20892, (301) 435–

0695, hardyan@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Social 

Science and Population Studies R03s, R15s, 

and R21s. 

Date: October 29, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, Washington, DC 20037.

Contact Person: Valerie Durrant, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3148, 

MSC 7770, Bethesda, MD 20892, (301) 435–

3554, durrantv@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Stem Cell 

Therapy and Ion Channels in the Heart. 

Date: October 29, 2004. 

Time: 10:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Four Points by Sheraton Bethesda, 

8400 Wisconsin Avenue, Bethesda, MD 

20814. 

Contact Person: Anshumali Chaudhari, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4124, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1210, chaudhaa@csr.nih.gov.

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Microcirculation and Hypertension. 

Date: October 29, 2004. 

Time: 1:15 p.m. to 2:15 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Latham Hotel, 3000 M Street, NW., 

Washington, DC 20007. 

Contact Person: Robert T. Su, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4134, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1195, sur@csr.nih.gov.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS)

Dated: September 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22310 Filed 10–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Asthma Exacerbations: Biology and Disease 

Progression. 

Date: October 27, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Columbia Hotel, 10207 

Wincopin Circle, Columbia, MD 21044. 

Contact Person: Arthur N. Freed, PhD, 

Review Branch, Room 7186, Division of 

Extramural Affairs, National Heart, Lung, and 

Blood Institute, National Institutes of Health, 

6701 Rockledge Drive, MSC 7924, Bethesda, 

MD 20892, (301) 435–0280.

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel, 

Review of Institutional National Research 

Service Award (T32) and Research Scientist 

Development Awards (K01s). 

Date: November 3, 2004. 

Time: 1 p.m. to 3:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

Contact Person: Zoe Huang, MD, Health 

Scientist Administrator, Review Branch, 

Room 7190, Division of Extramural Affairs, 

National Heart, Lung, and Blood Institute, 

National Institutes of Health, 6701 Rockledge 

Drive, MSC 7924, Bethesda, MD 20892–7924, 

301–435–0314.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart, and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS)

Dated: September 28, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–22312 Filed 10–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which